<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Thu, 15 Jan 2026 06:08:52 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>One in three people with cystic fibrosis may experience nephrolithiasis during their life</title><link>https://www.2minutemedicine.com/one-in-three-people-with-cystic-fibrosis-may-experience-nephrolithiasis-during-their-life/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>1. Nearly one in three people with cystic fibrosis experienced nephrolithiasis during their lifetime. 2. The degree of exocrine pancreatic insufficien...</description><pubDate>Thu, 15 Jan 2026 00:00:14 GMT</pubDate></item><item><title>Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates</title><link>https://www.2minutemedicine.com/nuzolvence-zoliflodacin-first-oral-gonorrhea-treatment-shows-non-inferior-cure-rates/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/09/gonorrhea-e1411353243851-300x150.jpg</image_url><description>1. Nuzolvence (zoliflodacin) is the first single‑dose oral agent for uncomplicated urogenital gonorrhea, showing non‑inferior cure rates to ceftriaxon...</description><pubDate>Wed, 14 Jan 2026 19:40:43 GMT</pubDate></item><item><title>Brain-penetrant enzyme replacement therapy improves biomarkers in mucopolysaccharidosis type II</title><link>https://www.2minutemedicine.com/brain-penetrant-enzyme-replacement-therapy-improves-biomarkers-in-mucopolysaccharidosis-type-ii/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/11/FMRI_Brain_Scan-e1421476109965.jpg</image_url><description>1. In this open-label phase 1–2 study, pediatric patients with mucopolysaccharidosis type II treated with tividenofusp alfa showed substantial reducti...</description><pubDate>Wed, 14 Jan 2026 16:00:29 GMT</pubDate></item><item><title>Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery</title><link>https://www.2minutemedicine.com/metformin-is-associated-with-lowering-maternal-hyperglycemia-and-reducing-the-risk-of-neonatal-hypoglycemia-among-pregnant-patients-at-risk-of-preterm-delivery/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2018/06/freestocks-org-71789-unsplash-300x150.jpg</image_url><description>1. Among pregnant patients at risk of preterm delivery, metformin was associated with lower mean maternal glucose values and a lower rate of neonatal ...</description><pubDate>Wed, 14 Jan 2026 00:00:59 GMT</pubDate></item><item><title>Aerobic-resistance training and high-intensity interval training may improve metabolic and functional outcomes in adults with type 2 diabetes</title><link>https://www.2minutemedicine.com/comparative-effects-of-combined-aerobic-and-resistance-training-versus-high-intensity-interval-training-on-insulin-resistance-glycaemic-control-body-composition-and-quality-of-life-in-type-2-diabete/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/05/teendiabetes_pd_edited-300x150.jpg</image_url><description>1. 12 weeks of aerobic–resistance training and high-intensity interval training improved metabolic, functional, and quality-of-life outcomes in adults...</description><pubDate>Tue, 13 Jan 2026 17:25:39 GMT</pubDate></item></channel></rss>